DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3Rahul S. Bhansali, John D. Crispino, Malini Rammohan et al.|Journal of Clinical Investigation|2021Cited by 92
Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Éric Delabesse et al.|Clinical Cancer Research|2020Cited by 23
Supplementary Data from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Unknown|2023Cited by 0
Supplementary Table 3 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Unknown|2023Cited by 0
Supplementary Table 2 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Unknown|2023Cited by 0